Invention Grant
US08829165B2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
有权
抗原结合蛋白与蛋白转化酶枯草杆菌蛋白酶Kexin 9型（PCSK9）
- Patent Title: Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
- Patent Title (中): 抗原结合蛋白与蛋白转化酶枯草杆菌蛋白酶Kexin 9型（PCSK9）
-
Application No.: US13860016Application Date: 2013-04-10
-
Publication No.: US08829165B2Publication Date: 2014-09-09
- Inventor: Simon Mark Jackson , Nigel Pelham Clinton Walker , Derek Evan Piper , Wenyan Shen , Chadwick Terence King , Randal Robert Ketchem , Christopher Mehlin , Teresa Arazas Carabeo
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen, Inc.
- Current Assignee: Amgen, Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Knobbe, Martens, Olson & Bear LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/40
Abstract:
Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.
Public/Granted literature
- US20130245235A1 ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) Public/Granted day:2013-09-19
Information query
